Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Taipei City
Clinical trial register · Taiwan

Clinical Trials in Taipei City, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Taiwan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2865 matching records held by the registry are in this view. Synced 19 Nov 2026, 03:18 UTC
2865
Studies in scope
all four open statuses
1570
Recruiting now
open to new participants
340
Lead sponsors
across recruiting studies
Top sites
Taipei 1913 Taichung 997 Kaohsiung City 828 Tainan 739 Taoyuan 568

Trials with a site in Taipei City

50 of 2865 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Taiwan
Start
Not yet open
Correlation Between Soft Tissue Displacement and Functional Performance in Orthopedic Patients
NCT07870408Hamstring Muscle Strain, Adult Acquired Flatfoot Deformity, Ulnar Collateral Ligament Sprain After Reconstruction
National Taiwan University Hospital
Not applicable
80
Taipei City
2026-11
Recruiting
Bristol-Myers Squibb
Phase 3
850
Kaohsiung City, New Taipei City, Taipei City, Taoyuan City, Taichung, Tainan
2026-09-08
Recruiting
Plasmapheresis in Amyotrophic Lateral Sclerosis With Autoantibody Against NRIP 2 (PALADIN2)
NCT07726563Amyotrophic Lateral Sclerosis (ALS), Autoantibody, Plasmapheresis
National Taiwan University Hospital
Not applicable
20
Taipei City
2026-05-19
Recruiting
Jade Biosciences, Inc.
Phase 2
30
Kaohsiung City, Taichung, New Taipei City, Taipei City, Taipei, Taiyuan
2026-05-19
Active, closed
Merck Sharp & Dohme LLC
Phase 2
315
New Taipei City, Taipei City, Kaohsiung City, Tainan, Taipei, Taoyuan
2025-09-26
Recruiting
Pfizer
Phase 3
714
Tainan, Taipei City, Kaohsiung City, Taichung, Taipei
2025-07-23
Not yet open
Continuous Passive Motion to Prevent Ankle Contracture and Muscle Atrophy in Ventilated Patients
NCT07032051Ankle Contracture, Critically Ill Intensive Care Unit Patients, Muscle Atrophy
Shin Kong Wu Ho-Su Memorial Hospital
Not applicable
20
Taipei City
2025-06-25
Recruiting
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 3
440
Taipei City, Taichung, Taipei
2025-03-12
Active, closed
Comparisons of the Effects and Clinical Outcomes of CH2 Vaginal Gel Versus Placebo on CIN1
NCT06582004Cervical Intraepithelial Neoplasia, Human Papillomavirus
National Taiwan University Hospital
Not applicable
50
Taipei City
2024-09-30
Active, closed
Stemline Therapeutics, Inc.
Phase 3
4,556
Taichung, New Taipei City, Taipei City, Taipei, Taiyuan, Changhua, Tainan
2024-09-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
3,000
New Taipei City, Tainan, Taipei City, Changhua, Kaohsiung City, Taipei, Taoyuan
2024-08-05
Recruiting
Merck Sharp & Dohme LLC
Phase 3
851
Taipei City, Taoyuan City, Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2024-06-10
Recruiting
Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)
NCT06295731Head and Neck Squamous Cell Carcinoma (HNSCC), HPV Oropharyngeal Squamous Cell Carcinoma (HPV+ OPSCC)
Inhibrx Biosciences, Inc
Phase 2/3
450
Taipei, Taichung, Taipei City, Changhua, Kaohsiung City, Tainan
2024-05-14
Recruiting
Merck Sharp & Dohme LLC
Phase 3
614
Tainan, Taipei City, Hsinchu, Kaohsiung City, New Taipei City, Taichung, Taipei
2023-12-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
868
Taipei City, Changhua, Hsinchu, Taichung, Tainan, Taipei
2023-12-06
Recruiting
Akero Therapeutics, Inc
Phase 3
1,650
Changhua, Taichung, Tainan, Taipei City, Kaohsiung City, Taoyuan
2023-12-01
Active, closed
AbbVie
Phase 3
289
Taipei City, Changhua, Chiayi City, New Taipei City, Taichung, Taoyuan City
2023-11-15
Recruiting
Shanghai Junshi Bioscience Co., Ltd.
Phase 3
756
Taipei City, Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2023-11-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
556
Tainan, Taipei City, Changhua, Hsinchu, Kaohsiung City, Taipei
2023-11-12
Recruiting
Merck Sharp & Dohme LLC
Phase 3
735
Taipei City, Kaohsiung City, Tainan, Taipei
2023-08-08
Active, closed
AbbVie
Phase 3
1,014
Taipei City, Keelung, Taichung
2023-07-25
Recruiting
Taipei Veterans General Hospital, Taiwan
Not applicable
200
Taipei City, Taipei
2023-07-24
Active, closed
Nalo Therapeutics Inc.
Phase 1
258
Taipei City
2022-10-05
Active, closed
Eli Lilly and Company
Phase 3
925
Taipei City, Taichung, Tainan, Taoyuan
2022-04-14
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,800
Kaohsiung Niao Sung Dist, Taipei City, Kaohsiung City, Taichung, Taipei, Taoyuan
2022-03-15
Active, closed
Eli Lilly and Company
Phase 3
152
Changhua County, Kaohsiung Niao Sung Dist, Taichung, Tainan, Taipei City, Kaohsiung City, Taipei, Taoyuan
2021-12-20
Active, closed
AbbVie
Phase 1
520
Kaohsiung City, Taipei City, Changhua City, Changhua County, Taichung, Tainan, Taipei, Taoyuan City
2021-10-13
Active, closed
Loxo Oncology, Inc.
Phase 3
500
Taipei City, Chiayi County, Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan City
2021-04-08
Active, closed
Loxo Oncology, Inc.
Phase 3
238
Taichung, Taipei City, Taoyuan, (r.o.c.), Taipei
2021-03-09
Active, closed
AbbVie
Phase 3
330
Kaohsiung City, Tainan, Taipei City, Taichung, Taipei, Taoyuan City
2020-08-31
Active, closed
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
NCT03844048Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, Multiple Myeloma, Non-Hodgkin's Lymphoma
AbbVie
Phase 3
165
Taipei City, Taichung
2019-09-06
Active, closed
AbbVie
Phase 2
270
Kaohsiung City, Taipei City, Chiayi City, New Taipei City, Taichung, Tainan, Taipei, Taoyuan City
2018-10-10
Active, closed
AbbVie
Phase 3
1,242
Taipei City, Taichung, Taipei, Taoyuan City
2018-08-28
Active, closed
Eli Lilly and Company
Phase 3
5,637
Kaohsiung Niao Sung Dist, Taipei City, Changhua, Kaohsiung City, New Taipei City, Taichung, Taipei, Taoyuan City
2017-07-12
Active, closed
AbbVie
Phase 3
950
Taipei City, Kaohsiung City, Taichung, Tainan, Taipei
2017-01-31
Active, closed
AbbVie
Phase 3
1,629
Taichung, Taipei City, Kaohsiung City, New Taipei City, Taipei, Taoyuan City
2015-12-01
Active, closed
AbbVie
Phase 1
237
Taichung, Tainan, Taipei City, Taipei
2014-01-15
Rows per page Showing 1–50 of 50
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Taiwanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 November 2026. https://priyalifescience.com/clinical-trials-taiwan/city/taipei-city

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Taiwan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,865 studies in total at the last sync on 19 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 50 of those studies with a site in Taipei City.

How many clinical trials are recruiting in Taipei City?

15 of the 50 studies on this page are recruiting new participants as of the 19 Nov 2026, 03:18 UTC sync. A further 2 have not yet opened recruitment, 33 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Taipei City), 50 studies
PhaseStudiesRecruitingShare
Phase 3331166%
Phase 26112%
Not applicable5210%
Phase 15010%
Phase 2/3112%

Most active sponsors

Lead sponsors with the most studies (Taipei City)
Lead sponsorStudiesRecruiting
AbbVie150
Merck Sharp & Dohme LLC124
Eli Lilly and Company30
National Taiwan University Hospital31
Genmab20
Loxo Oncology, Inc.20
Akero Therapeutics, Inc11
Bristol-Myers Squibb11
Inhibrx Biosciences, Inc11
Jade Biosciences, Inc.11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.